Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 22 tags : Alliances save search
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
Published: 2022-02-22 (Crawled : 21:00) - biospace.com/
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 3.24%
H: 0.18%
C: -1.6%
partnership program respiratory one
Kiniksa Pharmaceuticals and Huadong Medicine Announce Strategic Collaboration
Published: 2022-02-22 (Crawled : 20:00) - biospace.com/
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.3%
H: 0.92%
C: -1.7%
KNSA | $17.85 0.96% 0.95% 370K
|
Health Technology
|
| O: 1.31%
H: 0.0%
C: -2.21%
als collaboration
Akebia Therapeutics Announces Amendment of License Agreement with Vifor Pharma in Preparation for Potential Vadadustat Launch
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
AKBA | $1.36 -0.73% -0.74% 1.5M
|
Health Technology
|
| O: 0.55%
H: 11.54%
C: 8.24%
license therapeutics potential pharma
Actinium Pharmaceuticals, Inc. and AVEO Oncology Enter Research Collaboration Agreement to Develop First-in-Class Actinium-225 ErbB3 Targeting Radiotherapy for Solid Tumors
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -0.58%
H: 1.18%
C: -1.18%
ATNM | $7.06 1.44% 0.0% 150K
|
Health Technology
|
| O: -1.18%
H: 3.39%
C: 0.2%
als solid tumors research therapy collaboration iot
CDC Partners with Palantir to Bolster the Fight Against COVID-19
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
PLTR | $21.59 -0.23% -0.7% 33M
|
Technology Services
|
| O: -2.9%
H: 4.53%
C: -2.06%
covid-19 covid
Element Biosciences Partners with QIAGEN to Validate a Selection of QIAseq Targeted Library Construction Chemistries on Element’s AVITI™ System
Published: 2022-02-22 (Crawled : 14:00) - biospace.com/
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: -0.12%
H: 1.97%
C: 1.19%
QGEN | $41.52 -0.88% 0.0% 820K
|
Health Technology
|
| O: -0.12%
H: 1.97%
C: 1.19%
system bioscience
dievini and Related Parties Underline Their Strong Commitment as Shareholders of Curevac N.V. And Do No Longer Plan to Sell Shares to The Public
Published: 2022-02-22 (Crawled : 13:00) - biospace.com/
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -1.62%
H: 8.58%
C: 6.87%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.